BernardJGershMD

PubMed

• A Pragmatic Study of Cardiovascular Disease During Long-Term COVID-19.
  James F Howick V, Mohamed Elwazir, John C O'Horo, Leslie T Cooper Jr, Petar Saric, Darrell B Newman, Patricia A Pellikka, Abhishek J Deshmukh, Ravindra Ganesh, Ryan Hu...> ;The American Journal of Medicine. 2024 Mar 26
• 1 citations
  Re-evaluating the Incidence and Prevalence of Clinical Hypertrophic Cardiomyopathy: An Epidemiological Study of Olmsted County, Minnesota.
  Karim, S., Chahal, C., Khanji, M., Scott, C., Chamberlain, A., Brady, P., Sherif, A., Geske, J., Ommen, S., Gersh, B., Somers, V., Lin, G.> ;Mayo Clinic Proceedings. 2024 Mar 1
• Daylight Saving Time Practice and the Rate of Adverse Cardiovascular Events in the United States: A Probabilistic Assessment in a Large Nationwide Study.
  Van Houten, H., Yao, X., Satterfield, B., Dikilitas, O., Gersh, B.> ;Mayo Clinic Proceedings. Innovations, Quality & Outcomes. 2024 Feb 1
• 1 citations
  Coronary spasm and vasomotor dysfunction as a cause of MINOCA.
  Yaker, Z., Lincoff, A., Zieminski, J., Holmes, D., Cho, L., Ellis, S., Ziada, K., Gulati, R., Gersh, B., Raphael, C.> ;Eurointervention. 2024 Jan 15
• Country and health expenditure are major predictors of withholding anticoagulation in atrial fibrillation patients at high risk of stroke.
  Siegal, D., Verbrugge, F., Martin, A., Virdone, S., Camm, J., Pieper, K., Goto, S., Turpie, A., Angchaisuksiri, P., Fox, K., Gersh, B.> ;Open Heart. 2023 Dec 14
• AfricaSTEMI Live! 2023-a unique learning experience.
  Habib Gamra, Bernard Gersh, Mohamed Jeilan> ;European Heart Journal. 2024 Jan 14
• Clinical Outcomes in Older Patients with Atrial Fibrillation: Insights from the GARFIELD-AF Registry.
  Samuel Z Goldhaber, Jean-Pierre Bassand, A John Camm, Saverio Virdone, Karen Pieper, Frank Cools, Ramon Corbalan, Bernard J Gersh, Shinya Goto, Sylvia Haas, Frank Miss...> ;The American Journal of Medicine. 2024 Feb 1
• 9 citations
  Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection.
  Gerd Heusch, Ioanna Andreadou, Robert Bell, Edoardo Bertero, Hans-Erik Botker, Sean M Davidson, James Downey, Philip Eaton, Peter Ferdinandy, Bernard J Gersh, Mauro Gi...> ;Redox Biology. 2023 Nov 1
• Persistence of left atrial thrombus in patients with hypertrophic cardiomyopathy and atrial fibrillation.
  Daniel R Burczak, Christopher G Scott, Raghav R Julakanti, Abdalla Kara Balla, William H Swain, Khaled Ismail, Jeffrey B Geske, Ammar M Killu, Abhishek J Deshmukh, Cio...> ;Journal of Interventional Cardiac Electrophysiology. 2023 Sep 16
• Outcomes of Oral Anticoagulation in Atrial Fibrillation Patients With or Without Comorbid Vascular Disease: Insights From the GARFIELD-AF Registry.
  Freek W A Verheugt, Keith A A Fox, Saverio Virdone, Giuseppe Ambrosio, Bernard J Gersh, Sylvia Haas, Karen S Pieper, Gloria Kayani, A John Camm, Alexandr Parkhomenko, ...> ;The American Journal of Medicine. 2023 Dec 1
• Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD-AF and ORBIT-AF registries.
  Toon Wei Lim, Alan John Camm, Saverio Virdone, Daniel E Singer, Jean P Bassand, Gregg C Fonarow, Keith A A Fox, Michael Ezekowitz, Bernard J Gersh, Gloria Kayani, Elai...> ;Clinical Cardiology. 2023 Nov 1
• Physicians' perspectives on percutaneous left atrial appendage occlusion for patients with atrial fibrillation.
  Devika Kir, Holly K Van Houten, Kelli N Walvatne, Emma M Behnken, Mohamad Adnan Alkhouli, Jonathan Graff-Radford, Rowlens M Melduni, Bernard J Gersh, Paul A Friedman, ...> ;American Heart Journal. 2023 Dec 1
• Heart rate and death and hospitalization for heart failure in patients with persistent or permanent atrial fibrillation: Insights from the ARISTOTLE trial.
  Dragos Vinereanu, Daniel M Wojdyla, John H Alexander, Renato D Lopes, Sana M Al-Khatib, Bernard J Gersh, M Cecilia Bahit, Stefan H Hohnloser, Greg C Flaker, Marten Ros...> ;American Heart Journal. 2023 Nov 1
• Contemporary trends and barriers to oral anticoagulation therapy in Non-valvular atrial fibrillation during DOAC predominant era.
  Ojasav Sehrawat, Anthony H Kashou, Holly K Van Houten, Ken Cohen, Henry Joe Henk, Bernard J Gersh, Neena S Abraham, Jonathan Graff-Radford, Paul A Friedman, Konstantin...> ;International Journal of Cardiology. Heart & Vasculature. 2023 Jun 1
• Healthcare Resource Utilization in Patients with Newly Diagnosed Atrial Fibrillation: A Global Analysis from the GARFIELD-AF Registry.
  Lorenzo G Mantovani, Paolo Cozzolino, Pietro Ferrara, Saverio Virdone, A John Camm, Freek W A Verheugt, Jean-Pierre Bassand, Alexander G G Turpie, Werner Hacke, Gloria...> ;Healthcare. 2023 Feb 21
• 3 citations
  Revascularization in ischaemic cardiomyopathy: how to interpret current evidence.
  Bernard J Gersh, David De Mets> ;European Heart Journal. 2023 Feb 1
• 14 citations
  Association between acute disease severity and one-year quality of life among post-hospitalisation COVID-19 patients: Coalition VII prospective cohort study.
  Regis Goulart Rosa, Alexandre Biasi Cavalcanti, Luciano César Pontes Azevedo, Viviane Cordeiro Veiga, Denise de Souza, Rosa da Rosa Minho Dos Santos, Raíne Fogliati de...> ;Intensive Care Medicine. 2023 Feb 1
• The need for new clinical trials of old cardiovascular drugs.
  Christopher B Granger, Stuart J Pocock, Bernard J Gersh> ;Nature Reviews. Cardiology. 2023 Feb 1
• 4 citations
  A Practical Approach to Left Main Coronary Artery Disease: JACC State-of-the-Art Review.
  Laura J Davidson, Joseph C Cleveland, Frederick G Welt, Saif Anwaruddin, Robert O Bonow, Michael S Firstenberg, Mario F Gaudino, Bernard J Gersh, Kendra J Grubb, Ajay ...> ;Journal of the American College of Cardiology. 2022 Nov 29
• Syncope in hypertrophic cardiomyopathy: Explaining the unexplained.
  Jeffrey B Geske, Konstantinos C Siontis, Bernard J Gersh> ;International Journal of Cardiology. 2023 Feb 15
• 1 citations
  Valvular Heart Disease: New Concepts in Pathophysiology and Therapeutic Approaches.
  Mackram F Eleid, Vuyisile T Nkomo, Sorin V Pislaru, Bernard J Gersh> ;Annual Review of Medicine. 2023 Jan 27
• 1 citations
  Natural language processing for identification of hypertrophic cardiomyopathy patients from cardiac magnetic resonance reports.
  Nakeya Dewaswala, David Chen, Huzefa Bhopalwala, Vinod C Kaggal, Sean P Murphy, J Martijn Bos, Jeffrey B Geske, Bernard J Gersh, Steve R Ommen, Philip A Araoz, Michael...> ;BMC Medical Informatics and Decision Making. 2022 Oct 18
• 46 citations
  Artificial intelligence-guided screening for atrial fibrillation using electrocardiogram during sinus rhythm: a prospective non-randomised interventional trial.
  Peter A Noseworthy, Zachi I Attia, Emma M Behnken, Rachel E Giblon, Katherine A Bews, Sijia Liu, Tara A Gosse, Zachery D Linn, Yihong Deng, Jun Yin, Bernard J Gersh, J...> ;Lancet. 2022 Oct 8
• 9 citations
  Percutaneous Left Atrial Appendage Occlusion in Comparison to Non-Vitamin K Antagonist Oral Anticoagulant Among Patients With Atrial Fibrillation.
  Peter A Noseworthy, Holly K Van Houten, Harlan M Krumholz, David M Kent, Neena S Abraham, Jonathan Graff-Radford, Mohamad Alkhouli, Henry J Henk, Nilay D Shah, Bernard...> ;Journal of the American Heart Association. 2022 Oct 4
• 4 citations
  Mavacamten Treatment for Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
  Mahmoud Ismayl, Muhannad Aboud Abbasi, Rosalyn Marar, Jeffrey B Geske, Bernard J Gersh, Nandan S Anavekar> ;Current Problems in Cardiology. 2023 Jan 1
• Join now to see all

Journal Articles

• Association of New-Onset Atrial Fibrillation After Noncardiac Surgery with Subsequent Stroke and Transient Ischemic Attack  
  Konstantinos C Siontis, Bernard J Gersh, Peter A Noseworthy, JAMA
• Association of Surgical Left Atrial Appendage Occlusion with Subsequent Stroke and Mortality Among Patients Undergoing Cardiac Surgery  
  Rowlens M. Melduni, Bernard J. Gersh, David R. Holmes, Peter A. Noseworthy, Daniel O. Johnsrud, JAMA
• Hypertrophic Cardiomyopathy  
  Jeffrey B Geske, Steve R Ommen, Bernard J Gersh, ScienceDirect
• D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation - observations from the aristotle trial  
  Christersson C, Wallentin L, Andersson U, Alexander JH, Ansell J, De Caterina R, Gersh BJ, Granger CB, Hanna M, Horowitz JD, Huber K, Husted S, Hylek EM, Lopes RD, Sie..., J Thromb Haemost, 9/1/2014
• Translation of regenerative technologies into clinical paradigms reply  
  Behfar A, Crespo-Diaz R, Terzic A, Gersh BJ, Nat Rev Cardiol, 9/1/2014
• Management of Symptomatic Hypertrophic Cardiomyopathy: Pills, Alcohol, or the Scalpel?  
  Gersh BJ, Nishimura RA, Rev Esp Cardiol, 5/1/2014
• Work is fun and fun is work  
  Sliwa K, Gersh B, Eur Heart J, 4/1/2013
• 2012 ESC STEMI guidelines and reperfusion therapy: Evidence-based recommendations, ensuring optimal patient management  
  Steg PG, James SK, Gersh BJ, Heart, 1/1/2013
• Response to letter regarding article, impact of the presence and extent of incomplete angiographic revascularization after percutaneous coronary intervention in acute ...  
  Rosner GF, Kirtane AJ, Genereux P, Lansky AJ, Cristea E, Weisz G, Parise H, Fahy M, Mehran R, Stone GW, Gersh BJ, Circulation, 1/1/2012
• Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: A secondary analysis of a randomised...  
  Lopes RD, Al-Khatib SM, Wallentin L, Yang H, Ansell J, Bahit MC, De Caterina R, Dorian P, Easton JD, Erol C, Ezekowitz JA, Gersh BJ, Granger CB, Hohnloser SH, Horowitz..., Lancet, 1/1/2012
• Strategies for multivessel revascularization in patients with diabetes  
  Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA, Lansky A, Boineau R, Weinbe..., N Engl J Med, 1/1/2012
• Response to letter regarding article, "Attained educational level and incident atherothrombotic events in low- and middle-income compared with high-income countries"  
  Goyal A, Bhatt DL, Steg PG, Gersh BJ, Alberts MJ, Ohman EM, Califf RM, Corbalan R, Eagle KA, Gaxiola E, Gao R, Goto S, D'Agostino RB, Smith SC, Wilson PWF, Circulation, 5/1/2011
• Antiplatelet and anticoagulant therapy for stroke prevention in patients with non-valvular atrial fibrillation: evidence based strategies and new developments  
  Gersh BJ, Freedman JE, Granger CB, Rev Esp Cardiol (Engl Ed), 4/1/2011
• A long way from Cape Town: A personal and professional journey from South Africa to the USA  
  Scholar R, Gersh BJ, Eur Heart J, 1/1/2011
• Hypotheses, rationale, design, and methods for prognostic evaluation in type 2 diabetic patients with angiographically normal coronary arteries The MASS IV-DM Trial  
  Hueb W, Lopes N, Soares PR, Gersh BJ, Lima EG, Vieira RD, Garzillo CL, Garcia RR, Pereira AC, Strunz CM, Meneguetti C, Tsutsui J, Parga J, Lemos P, Hueb A, Ushida A, M..., Bmc Cardiovascular Disorders, 9/1/2010
• Timing of intervention in patients undergoing invasive management for acute coronary syndromes  
  Sorajja P, Gersh BJ, Stone GW, J Am Coll Cardiol, 9/1/2010
• Antithrombotic therapy for the prevention of reinfarction after reperfusion therapy: the price of success  
  Gulati R, Gersh BJ, Rev Esp Cardiol (Engl Ed), 5/1/2009
• A randomized comparative study of patients undergoing myocardial revascularization with or without cardiopulmonary bypass surgery: The MASS III Trial - art no 52  
  Hueb W, Lopes NHM, Gersh BJ, Castro CC, Paulitsch FS, Oliveira SA, Dallan LA, Hueb AC, Stolf NA, Ramires JAF, Trials [Electronic Resource], 8/1/2008
• Can septal myectomy prevent sudden cardiac death in hypertrophic obstructive cardiomyopathy? reply  
  Ommen S, McLeod C, Ackerman M, Gersh B, Eur Heart J, 9/1/2007
• Holmes reply to Hakeem, letter to the editor - RE: Rescue percutaneous coronary intervention after failed fibrinolytic therapy: Have expectations been met?  
  Holmes DR, Gersh BJ, Am Heart J, 11/1/2006
• Aborted myocardial infarction: a new target for reperfusion therapy  
  Verheugt FWA, Gersh BJ, Armstrong PW, Eur Heart J, 4/1/2006
• Controversies in cardiology - Reply  
  Commerford PJ, Kaplan NM, Nattel S, Gersh BJ, Opie LH, Lancet, 4/1/2006
• The changing epidemiology of non-valvular atrial fibrillation: the role of novel risk factors  
  Gersh BJ, Tsang TSM, Barnes ME, Seward JB, Eur Heart J, 5/1/2005
• Alternative and complementary medical approaches in the prevention and treatment of cardiovascular disease  
  Frishman WH, Grattan JG, Mamtani R, Rahimtoola SH, Alpert JS, Bonow RO, Gersh BJ, O'Rourke RA, Scheinman MM, Smith SC Jr, Curr Probl Cardiol, 1/1/2005
• Mechanisms and treatment of obstructive sleep apnea - Reply  
  Shamsuzzaman ASM, Gersh BJ, Somers VK, JAMA, 2/1/2004
• Join now to see all

Books/Book Chapters

• Drugs for the heart. 
  Chapter: Antithrombotic agents: platelet inhibitors, acute anticoagulants, fibrinolytics, and chronic anticoagulants. 
  Page 332 - 397Fox KAA, White HD, Gersh BJ, Opie LHEditors: Opie LH; Gersh BJ.Elsevier/Saunders, Philadelphia, PAEdition 8th,2013
• Mayo Clinic cardiology: concise textbook. 
  Chapter: Implantable cardioverter-defibrillator trials and prevention of sudden cardiac death. 
  Page 349 - 356Lloyd MA, Gersh BJEditors: Murphy JG; et al.Mayo Clinic Scientific Press, Rochester, MNEdition 4th,2013
• Drugs for the heart. 
  Opie LH, Gersh BJElsevier/Saunders, Philadelphia, PAEdition 8th,2013
• Yearbook of Medicine 
  Editors: Bernard J, Gersh.2012
• Management of Acute Myocardial Infarction. 
  Chapter: Reperfusion therapy. 
  Page 55 - 70Cassar A, Gersh BJEditors: Opie LH, Gersh BJ.Elsevier, India2012
• 25 Anos de Cardiologia 
  Chapter: Acute Myocardial Infarction-Historical Notes. 
  Page 59 - 70Teixeira R, Goncalves L, Gersh BJEditors: Ferreira MJV, Goncalves LM.2012
• Landmark Papers in Cardiovascular Medicine. 
  Chapter: Medical versus invasive management of coronary heart disease. 
  Page 83 - 101Moody W, Gersh BEditors: Myat A, Gershlick AH.Oxford, United Kingdom2012
• Interventional Cardiology: Principals and Practice. 
  Chapter: Stable angina. 
  Page 213 - 231Prasad A, Gersh BEditors: Di Mario and Dangas.2011
• Hurst's the heart. 
  Chapter: ST-segment elevation myocardial infarction. 
  Page 1354 - 1385Hass EE, Yang EH, Gersh BJ, O'Rourke RAEditors: Fuster V; et al.McGraw-Hill Medical, New York, NYEdition 13th,2011
• Clinical guide to primary angioplasty. 
  Chapter: Utilization of facilitated and rescue angioplasty. 
  Page 143 - 152Gulati R, Gersh BJEditors: Brecker S; Rothman M.Informa Healthcare, New York, NY2010
• Evidence-based cardiology. 
  Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJWiley-Blackwell, Chichester; HobokenEdition 3rd,2010
• Evidence-based cardiology. 
  Chapter: Preface to the third edition. 
  Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJEdition 3rd,2010
• Sudden cardiac death: a handbook for clinical practice. 
  Chapter: Sudden cardiac death and valvular heart diseases. 
  Page 147 - 161Messika-Zeitoun D, Gersh BJ, Fondard O, Vahanian A2009
• Hurst's the heart manual of cardiology. 
  Chapter: Diagnosis and management of patients with ST-segment elevation myocardial infarction. 
  Page 285 - 295Yang EH, Gersh BJEditors: O'Rourke RA, Walsh RA, Fuster V.McGraw-Hill Medical, New York, NYEdition 12th,2009
• Drugs for the heart. 
  Chapter: Which therapy for which conditon? 
  Page 388 - 458Gersh BJ, Opie LHEditors: Opie LH, Gersh BJ.Saunders/Elsevier, Philadelphia, PAEdition 7th,2009
• Drugs for the heart. 
  Opie LH, Gersh BJSaunders/Elsevier, Philadelphia, PAEdition 7th,2009
• Interventional Cardiology: Principles and Practice 
  Chapter: Stable Angina. 
  Prasad A, Gersh BJEditors: Di Mario D, Dangas G, Barlis P.2008
• Hurst's the heart. 
  Chapter: Pharmacologic therapy for acute coronary syndromes. 
  Page 1405 - 1426Dellegrottaglie S, Gershlick AH, Chiariello M, Gersh BJEditors: Fuster V, et al.McGraw-Hill Medical, New York, NYEdition 12th,2008
• 900 questions: an interventional cardiology board review. 
  Chapter: Chronic stable angina: American College of Cardiology/American Heart Association guidelines. 
  Page 278 - 287Sorajja P, Gersh BEditors: Mukherjee D, et al.Walters Kluwer/Lippincott Williams & Wilkins, Philadelphia, PA2007
• Mayo Clinic cardiology: concise textbook. 
  Chapter: Fibrinolytic trials in acute myocardial infarction. 
  Page 855 - 868Best PJM, Gersh BJ, Murphy JGEditors: Murphy JG, Lloyd MA.Mayo Clinic Scientific Press: Informa Healthcare, Rochester, MNEdition 3rd,2007
• Cardiovascular medicine. 
  Chapter: Atrial fibrillation and flutter. 
  Page 1955 - 1978Brady PA, Gersh BJEditors: Willerson JT, et al.Springer, LondonEdition 3rd,2007
• Strategic approaches in coronary intervention. 
  Chapter: Complete versus incomplete revascularization. 
  Page 399 - 406Trost JC, Dries DL, Gersh BJEditors: Ellis SG, Holmes DR Jr.Lippincott Williams & Wilkins, Philadelphia, PAEdition 3rd,2006
• Textbook of Coronary Stenting. 
  Chapter: Stenting in the Patient with Diabetes Mellitus. 
  Orford J, Berger P, Gersh BJWB Saunders2005
• Drugs for the heart. 
  Chapter: Antiarrhythmic drugs and strategies. 
  Page 218 - 274DiMarco JP, Gersh BJ, Opie LHEditors: Opie LH, Gersh BJ.Elsevier Saunders, Philadelphia, PAEdition 6th,2005
• Drugs for the heart. 
  Chapter: Which therapy for which condition? 
  Page 349 - 412Gersh BJ, Opie LHEditors: Opie LH, Gersh BJ.Elsevier Saunders, Philadelphia, PAEdition 6th,2005
• Join now to see all

Abstracts/Posters

• Women with hypertrophic cardiomyopathy have worse survival.
  Geske J, Ong K, Hebl V, Ackerman M, Nishimura R, Gersh B, Ommen S, Circulation, 11/1/2013
• Nonobstructive hypertrophic cardiomyopathy: survival analysis in long-term follow-up.
  Hebl VB, Geske JB, Ong K, Gentile F, Ackerman MJ, Gersh BJ, Ommen SR, Circulation, 11/1/2013
• Combining high sensitivity troponin i and t measurements improves prediction of long-term clinical outcomes in patients with atrial fibrillation - an Aristotle substudy.
  Hijazi Z, Siegbahn A, Andersson U, Granger CB, Alexander JH, Atar D, Gersh BI, Hanna M, Harjola VP, Horowitz JD, Husted S, Hylek EM, Lopes RD, McMurray JJ, Wallentin L, Circulation, 11/1/2013
• Triple versus dual antithrombotic therapy in patients with atrial fibrillation and history of coronary artery disease: insights from the orbit-af registry.
  Lopes RD, Holmes DN, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Go AS, Hylek FM, Kowey PR, Piccini JP, Singer DE, Chang P, Peterson ED, Mahaffey KW, Circulation, 11/1/2013
• Transcatheter aortic valve replacement for high-risk severe aortic stenosis: an analysis of incidence, predictors and prognostic impact of new-onset postprocedural atr...
  Melduni RM, Greason KL, Suri RM, Nkomo VT, Rihal CS, Sarano ME, Gersh B, Holmes DR, Mathew V, Circulation, 11/1/2013
• Association between diabetic peripheral neuropathy and atrial fibrillation - a community based case control study.
  Nazmul MN, Melduni RM, Cha SS, Gersh BJ, Lee HC, Circulation, 11/1/2013
• Pulmonary hypertension in hypertrophic cardiomyopathy: prevalence, clinical profile, and prognosis.
  Ong KC, Geske JB, Coutinho TD, Hebl VB, Gersh BJ, Ackerman MJ, Rick NA, Ommen SR, Circulation, 11/1/2013
• Atrial fibrillation in hypertrophic cardiomyopathy: epidemiology and risk of death.
  Siontis KC, Geske JB, Ong K, Ommen SR, Gersh BJ, Circulation, 11/1/2013
• Trends in cause of long-term death after percutaneous coronary intervention.
  Spoon DB, Psaltis PJ, Singh M, Holmes DR, Gersh BK, Rihal CS, Lennon RJ, Moussa ID, Simari RD, Gulati R, Circulation, 11/1/2013
• Antithrombotic strategies and adverse outcomes in acute coronary syndrome and atrial fibrillation: a community study.
  Chamberlain AM, Gersh BJ, Klaskala W, Mills RM, Alonso A, Weston SA, Roger VL, Value Health, 11/1/2013
• Coronary artery bypass grafting history and acute coronary syndromes, meta-analysis.
  Teixeira R, Vieira MJ, Ribeiro MJ, Goncalves L, Gersh B, Eur Heart J, 8/1/2013
• Antithrombotic strategies in acute coronary syndrome and atrial fibrillation: A community perspective.
  Chamberlain AM, Gersh BJ, Klaskala W, Mills RM, Alonso A, Weston SA, Roger VL, Value Health, 5/1/2013
• Survival after incident atrial fibrillation: a community-based study.
  Chamberlain AM, Gersh BJ, Alonso A, Chen LY, Berardi C, McNallan SM, Weston SA, Roger VL, Circulation, 3/1/2013
• Yield of genetic testing among patients with hypertrophic cardiomyopathy diagnosed after 65 years of age.
  Bos JM, Will M, Ommen S, Gersh B, Ackerman M, J Am Coll Cardiol, 3/1/2013
• Pulmonary hypertension in hypertrophic cardiomyopathy: effect of septal reduction therapy.
  Geske JB, Konecny T, Ommen S, Nishimura R, Gersh B, J Am Coll Cardiol, 3/1/2013
• Systolic anterior motion of the anterior mitral leaflet and hypertrophic cardiomyopathy: a predictor of non-genetic, non-familial disease?
  Medford BA, Haugaa K, Bos J, Miller A, Ommen S, Gersh B, Johnson J, Cetta F, Eidem B, O'Leary P, Ackerman M, J Am Coll Cardiol, 3/1/2013
• Physiologic significance of left atrial appendage closure: implication for postoperative atrial fibrillation.
  Melduni R, Wiggins M, Suri R, Lee HC, Schaff H, Seward J, Gersh B, J Am Coll Cardiol, 3/1/2013
• Temporal trends in the cause of long-term death after pci: a 20-year single-center experience.
  Spoon DB, Psaltis PJ, Holmes D, Simari R, Gersh B, Lennon R, Moussa I, Gulati R, J Am Coll Cardiol, 3/1/2013
• Genotype-phenotype spectrum in apical variant hypertrophic cardiomyopathy.
  Towe EC, Bos M, Ommen S, Gersh B, Ackerman M, J Am Coll Cardiol, 3/1/2013
• Risk of stroke, systemic embolism or death according to heart failure and left ventricular function status in patients with atrial fibrillation: results of the ARISTOT...
  McMurray JJV, Lewis B, Ezekowitz J, Gersh B, Lopes RD, Wojdyla D, Mohan P, Wallentin L, Alexander JH, Granger CB, Eur Heart J, 8/1/2012
• Catheter ablation of atrial fibrillation in US community practice: results from ORBIT AF.
  Piccini J, Holmes D, Kowey P, Reiffel JA, Naccarelli G, Hylek E, Chang P, Gersh B, Peterson E, Eur Heart J, 8/1/2012
• Impact of atrial fibrillation on health care utilization among patients with myocardial infarction.
  Chamberlain AM, Bielinski SJ, Weston SA, Klaskala W, Mills RM, Gersh BJ, Roger VL, Value Health, 6/1/2012
• Prevalence and spectrum of hcm-associated mutations among over 1000 unrelated patients with hypertrophic cardiomyopathy (HCM).
  Bos JM, Will M, Sorajja P, Nishimura R, Gersh B, Ommen S, Ackerman M, J Am Coll Cardiol, 3/1/2012
• Valvular regurgitations associated with atrial fibrillation: a community based study.
  Vatury O, Michelena HI, Pislaru SV, Gersh BJ, Sarano ME, Cardiology, 1/1/2012
• Sleep disordered breathing is associated with higher heart rates in patients with hypertrophic cardiomyopathy despite rate control therapy.
  Konecny T, Brady PA, Ludka O, Orban M, Svatikova A, Edelhofer P, Shen T, Asirvatham SJ, Gersh BJ, Tajik JA, Ommen SR, Somers VK, Circulation, 11/1/2011
• Join now to see all

Lectures

• When the Primary Endpoint Is Missed: The CABANA Case Study 
  CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
• Lecture on Clinical Scient 2010 
  Stockholm, Sweden - 8/1/2010
• Update in Cardiology VI 
  Fuengirola, Spain - 1/1/2010
• Taiwan Transcatheter Therapeutics 
  Taiwan - 1/1/2010
• Sharing the Future in the Latest Advancements of Cellular Therapy & Genomics in Cardiovascular Disease 
  San Diego, CA - 2/1/2008
• Cardiovascular Forum 
  Pinhao, Portugal - 6/1/2006
• Cardiovascular Gene and Stem Cell Therapy (Invited Speaker) 
  Valladolid, Spain - 4/1/2005
• XII Cardiology for the Consultant Course (Invited Speaker) 
  Chclayo, Peru - 5/1/2004
• Cardiology 2004 (Invited Speaker) 
  Sydney, Australia - 4/1/2004
• Cardiology Today and Tomorrow: Practical Approaches to Management of Patients With Cardiovascular Disease. 
  Naples, Italy - 1/1/2004
• Temas Actuales en Cardiologia (Invited Speaker) 
  12/1/2003
• Coronoary Reperfusion & Secondary Prevention 
  Oberlech, Austria - 3/1/2003
• Coronary Revascularization in Diabetics: Clinical Implications of the Randomized Trials. Invited Lecturer 
  Appleton, WI - 5/1/2001
• Kyoto University International Collaborative Works on Myocarditis/Cardiomyopathy. Invited Lecturer 
  Kyoto, Japan - 3/1/2001
• First Courses in Advances in Cardiology. Invited Speaker 
  Ibero American University, San Juan, Costa Rica - 1/1/2001
• Cardiologia Para El Consultante 2000. Invited Speaker 
  Buenos Aires, Argentina - 11/1/2000
• The Original 2000 Philadelphia Board Review Course in Cardiovascular Diseases. Guest Speaker 
  Philadelphia, PA - 10/1/2000
• Acute Myocardial Infarction at the Dawn of the Next Millennium 
  Florence, Italy - 1/1/1999
• Coronary, Hypertensive, Valvular and Myocardial Heart Diseases: The Multidisciplinary Approach 
  American College of Cardiology, Williamsburg, VA - 12/1/1998
• 23rd Annual Arthur B. Richter Lecture on Clinical Cardiology 
  Indiana Heart Institute, St. Vincent's Hospital, Indianapolis, IN - 10/1/1998
• Cardiovascular Conference at Lake Louise 
  Lake Louise, Alberta, Canada - 1/1/1998
• Arrhythmias in Heart Failure 
  Stockholm, Sweden - 8/1/1997
• Transcatheter Technologies 
  Washington, DC - 3/1/1996
• 4th Annual Gordon Moor, MD Lecture 
  Lakeland, FL - 1/1/1996
• State-of-the-Art Lecture 
  Washington, DC - 1/1/1996
• Join now to see all

Other

• The STREAM Trial. Acute coronary syndromes (ACS) 
  Van de Werf F, Tarantini G, Gersh BJ, New England Journal of Medicine
  3/1/2013
• Stem Cells in Myocardial Injury. 
  Chih S, Gersh BJ, Coronary Care Manueal
  1/1/2011
• Ventricular function and hemodynamics in the dog during anesthesia. Thesis. 
  Gersh BJ, D. Phil.
  1/1/1970
• Overview of the care of patients with stable ischemic heart disease 
  Gersh BJ, Kannam JP, Aroesty JM
  http://www.uptodate.com/contents/overview-of-the-care-of-patients-with-stable-ischemic-heart-disease
  UpToDate, Wolters Kluwer Health - 2013-01-03
• Cardiac manifestations of Fabry disease and screening in patients with left ventricular hypertrophy 
  Gersh BJ
  http://www.uptodate.com/contents/cardiac-manifestations-of-fabry-disease-and-screening-in-patients-w
  UpToDate, Wolters Kluwer Health - 2011-04-08
• Join now to see all